SCHEMBL31526236

SCHEMBL31526236

Cc1noc(-c2ccccc2)c1CSC[C@H]1O[C@@H](n2cc(-c3ccc4ccccc4c3)c3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 8/20 0.52
▸ GNMT Q14749 1/20 0.51
▸ PRMT5 O14744 6/20 0.44
▸ METTL3 Q86U44 6/20 0.44
▸ NADK O95544 1/20 0.42
▸ DOT1L Q8TEK3 2/20 0.42
▸ PRMT3 O60678 1/20 0.42
▸ DNMT1 P26358 1/20 0.42
▸ NNMT P40261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31526186 0.93 ADK (0.58) ADKPRMT5NADKDOT1LPRMT3
SCHEMBL31526342 0.92 ADK (0.55) ADKPRMT5NADKDOT1LPRMT3
SCHEMBL31526202 0.90 ADK (0.49) ADKGNMTPRMT5METTL3DOT1L
SCHEMBL31526252 0.89 GNMT (0.54) ADKGNMTPRMT5METTL3NADK
SCHEMBL31526119 0.88 ADK (0.51) ADKPRMT5NADKDOT1LPRMT3
SCHEMBL31526135 0.88 ADK (0.51) ADKPRMT5METTL3DOT1LPRMT3
SCHEMBL31526373 0.88 ADK (0.51) ADKPRMT5METTL3DOT1LPRMT3
SCHEMBL31526349 0.88 ADK (0.47) ADKGNMTPRMT5METTL3DOT1L
SCHEMBL31526289 0.88 ADK (0.51) ADKPRMT5METTL3DOT1LPRMT3
SCHEMBL31526392 0.87 ADK (0.49) ADKGNMTPRMT5NADKDOT1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025098545-A1 NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) 2025-05-15 — — WO disclosed
EP-4553080-A1 NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) 2025-05-14 — — EP disclosed
Send feedback